GDG: Wealth Platform - A Tax Trick Worth Billions?
GDG: Wealth Platform - A Tax Trick Worth Billions?
In a Nutshell
Executive Summary
In a Nutshell
Generation Development Group runs a three-part wealth platform — investment bonds (Gen Life), managed accounts (Evidentia), and investment research (Lonsec) — all wrapped inside a structure that pays tax at roughly half the corporate rate. At A$4.68 versus our fair value of A$3.87, the stock is 21% overvalued. The business is genuinely excellent; the price has simply run ahead of what one reporting period can verify.
Investor Profiles
| Profile | Rating | Rationale |
|---|---|---|
| Income | ★★☆☆☆ | The forecast dividend yield is under 1% at current prices, rising to roughly 1.5% by FY28. Payout ratios are intentionally low at 22–25% as the company reinvests for growth. Income investors will find better yield elsewhere for the next several years. |
| Value | ★★☆☆☆ | At 21% above our fair value of A$3.87, the margin of safety is negative. The stock trades at roughly 20x forward EV/EBITDA — already embedding the structural thesis that peers like HUB24 and Netwealth took years to earn. Re-rating from here requires flawless execution rather than discovery. |
| Growth | ★★★★☆ | Revenue is forecast to grow from A$141m to A$260m over three years — a 22% compound rate. Evidentia alone tripled its revenue contribution between FY25 and FY26 as mandate migrations came through. The managed accounts sector is growing at 15–17% annually, and GDG is taking share. |
| Quality | ★★★★☆ | The business scores 8 out of 10 for quality. EBITDA margins of 41% reflect the structural tax advantage of the friendly society wrapper, and Lonsec retains over 95% of subscribers annually. The caution is that ROIC of 14% barely clears the 11.6% cost of capital on a goodwill-heavy balance sheet. |
| Thematic | ★★★★☆ | GDG sits at the intersection of three structural Australian trends: Division 296 tax changes driving demand for investment bonds, the managed accounts sector compounding at 15–17% annually, and a $5.4 trillion intergenerational wealth transfer over the next two decades. No other ASX-listed company captures all three simultaneously. |
GDG is best suited to growth and thematic investors with a two-to-three year horizon. The revenue trajectory is compelling and the structural tailwinds are real. But the current price demands patience — the thesis needs another year of verified results before the premium is fully justified.
Executive Summary
Generation Development Group makes money three ways: it sells investment bonds through Gen Life (earning a spread on $5.5bn in funds under management), charges managed account fees through Evidentia, and sells investment research subscriptions through Lonsec. The platform's defining structural advantage is its friendly society licence — a regulatory wrapper that allows the group to pay tax at roughly 18% rather than the standard 30%, adding several hundred basis points to every margin line.
The first half of FY26 was the group's strongest on record. Management underlying NPAT of A$20.1m represented 63% growth on the prior year. Revenue reached A$88.4m for the half as Evidentia's mandate migrations accelerated, Gen Life posted record investment bond sales, and Lonsec's subscriber base continued to grow. Management guided the second half to exceed the first.
The investment case is straightforward in theory: a wide-moat platform with three recurring revenue streams, structural sector tailwinds, and a permanent tax advantage that competitors cannot replicate without acquiring an APRA-licenced life company. The complication is price. At A$4.68 versus our fair value of A$3.87, the stock is 21% overvalued.
Results & Outlook
What Happened
The first half of FY26 delivered revenue of A$88.4m and underlying NPAT of A$20.1m — numbers that would have represented a full-year result just two years ago. The growth was broad-based. Gen Life achieved record investment bond inflows as Division 296 legislation pushed high-balance superannuation holders toward alternative tax structures. Evidentia migrated over A$2bn in new mandates during the third quarter alone. Lonsec added subscribers while maintaining pricing.
| Metric | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|
| Revenue (A$m) | 141.3 | 185.0 | 221.0 | 260.0 |
| EBITDA (A$m) | 58.3 | 76.0 | 93.0 | 110.0 |
| EBITDA Margin (%) | 41.3 | 41.1 | 42.1 | 42.3 |
| EPS (A¢) | 8.2 | 9.7 | 13.6 | 17.7 |
| Gen Life FUM (A$bn) | 4.4 | 5.5 | 6.7 | 8.0 |
| Evidentia Revenue (A$m) | 6.7 | 65.0 | 80.0 | 96.0 |
What's Next
The near-term outlook hinges on two variables. First, the Division 296 legislation. If the Senate passes the bill targeting superannuation balances above A$3m, investment bond demand accelerates materially — we estimate a A$0.70 per share uplift in a passage scenario. Defeat would remove a significant tailwind, though structural demand for investment bonds persists regardless. Second, Evidentia's FUM trajectory. The business needs to demonstrate that the A$2bn-plus of Q3 mandate migrations convert into sticky, fee-generating relationships rather than transitional flows. The FY26 full-year result in August 2026 provides the second clean combined data point — it is the key milestone for thesis validation.
Valuation & Risks
| Metric | Value |
|---|---|
| Fair Value | A$3.87 |
| Current Price | A$4.68 |
| Downside to Fair Value | −17% |
| Bull Case (15% probability) | A$5.24 |
| Bear Case (22% probability) | A$2.80 |
| WACC | 11.6% |
| Effective Tax Rate Assumed | 18% (structural) |
The single biggest risk is one that management never discusses publicly: the friendly society tax structure. Our entire valuation advantage — the 18% effective tax rate versus the standard 30% — rests on this regulatory wrapper remaining intact. It has existed for over 50 years and any change would require amending the Life Insurance Act, but a threat to it would not appear in GDG's own disclosures. Investors should monitor federal budget announcements and any Treasury review touching friendly societies. A reversion to standard corporate tax rates would reduce our fair value by approximately A$0.45 per share at the terminal level alone, and the earnings impact in the near term would be immediate and material. The second risk is correlation: Division 296 defeat combined with a 15–20% equity market correction would compress both investment bond demand and Evidentia's FUM simultaneously — the bear case scenario at A$2.80 reflects exactly this combination.